Skip to main content

Fundamental and Clinical Studies on New Bleomycin Analogs

  • Chapter
Antitumor Antibiotics

Abstract

In the last 15 years, there has been great progress in the study of antitumor antibiotics. Professor Umezawa in his early study on bleomycin (BLM) proposed the following principle: Even a cytotoxic agent may exhibit therapeutic action against certain types of tumors if it is distributed in the tumor in a higher concentration than in other tissues, or if it is not inactivated or activated in those tumors. This principle has been exemplified by the study of BLM.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ichikawa, T.: Bleomycin, a new antitumor antibiotic. J. Jap. Med. Assoc. 61, 487–497 (1969).

    CAS  Google Scholar 

  2. Kurihara, M., Shirakabe, H., Murakami, T., Yasui, A., Izumi, T., Sumida, M., Igarashi, A.: A new method for producing adenocarcinoma in the stomach of dogs with N-ethyl-N’-nitro-N-nitrosoguanidine. GANN. 65, 163–177 (1974).

    PubMed  CAS  Google Scholar 

  3. Sugimura, T., Fujimura, S., Baba, T.: Tumor production in the glandular stomach and alimentary tract of rat by N-Methyl-N′-nitro-N-nitrosoguanidine. Cancer Res. 30, 455–465 (1970).

    PubMed  CAS  Google Scholar 

  4. Umezawa, H.: Bleomycin: Discovery, Chemistry, and Action In: Fundamental and clinical studies of bleomycin. GANN Monograph on Cancer Research No. 19, Carter, S. K., Ichikawa, T., Mathé, G., and Umezawa, H. (ed.) 3–36, University of Tokyo Press (1976).

    Google Scholar 

  5. Umezawa, H.: Chemistry and mechanism of action of bleomycin. Federation Proc. 33, 2296–2302 (1974).

    CAS  Google Scholar 

  6. Umezawa, H., Takeuchi, T., Hori, S., Sawa, T., Ishizuka, M., Ichikawa, T., Komai, T.: Studies on the mechanism of antitumor effect of bleomycin on squamous cell carcinoma. J. Antibiotics 25, 409–420 (1974).

    Google Scholar 

  7. Yoshioka, O., Yamaguchi, S., Matsuda, A., Umezawa, H.: The role of nude mice as new assay system in research on cancer chemotherapeutic agents. Jap. J. Cancer Clin. 22, 707–713 (1976).

    CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1978 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Matsuda, A. et al. (1978). Fundamental and Clinical Studies on New Bleomycin Analogs. In: Carter, S.K., Umezawa, H., Douros, J., Sakurai, Y. (eds) Antitumor Antibiotics. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 63. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81219-4_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-81219-4_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-81221-7

  • Online ISBN: 978-3-642-81219-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics